Stem cell treatment: the complete process

Stem cell treatment. A decision that begins with information.

When someone starts researching stem cell treatment, they are rarely looking for a specific procedure. They want to understand whether it is worth considering, whether it is safe, and what to expect at each stage. That is exactly the conversation worth having before making any decision.

At Longevia Medical, in Puerto Cancún, regenerative medicine is led by Dr. María Guadalupe Navarro Barrientos, Physician and Homeopath (IPN), with a Master's degree in Molecular Biomedicine (IPN) and a Doctorate in Medical Research from the Escuela Superior de Medicina del IPN. What we describe here is the general process that a well-structured stem cell intervention follows in a regulated medical setting, so you arrive at your assessment with clear questions rather than expectations built on gaps.

What stem cells are and what can be asked of them

Stem cells are cells capable of renewing themselves and differentiating into more specialized cell types. That property is the basis of their medical use: under the right conditions, they can contribute to the repair or replacement of damaged tissue.

There are distinct types depending on their origin and degree of specialization. The most widely used in clinical medicine are mesenchymal stem cells, present in adult tissues. Their behavior in the body depends on the environment where they are applied, the condition of the recipient tissue, and the route of administration, among other factors.

What the evidence supports today is their use in certain hematological diseases, where stem cell transplantation is an established procedure. In other areas, such as joint regeneration, autoimmune diseases, or neurological conditions, there are active lines of research and results that justify further study, but the practice has not yet been uniformly validated for general use. That distinction matters, and any clinic that erases it deserves to be questioned.

The difference between what is accepted and what remains under investigation is not a minor detail: it is the foundation of an informed decision.

The stem cell treatment process: stage by stage

A well-structured stem cell treatment does not begin with the application. It begins well before, with a complete reading of the patient's health status, and continues well after, with follow-up. Here is the general sequence.

Initial assessment

Before any regenerative protocol, the patient's overall health is reviewed: clinical history, recent laboratory work, coexisting conditions, active medications, and the objective of the intervention. This stage determines whether there is a real indication, which approach is most appropriate, and whether any contraindications exist.

The assessment may be in person or remote. In either case, the result is an individual plan delivered in writing, not a generic proposal.

Protocol definition

There is no single protocol for stem cell treatment. The number of sessions, the cell type, the route of administration, and the intermediate objectives are defined case by case. What works for a joint condition does not necessarily apply to an autoimmune condition, and what applies to a forty-year-old patient may not apply to a sixty-five-year-old with a different clinical history.

The protocol also establishes what will be measured and how often, so there is a clear basis for knowing whether the intervention is meeting its purpose or needs adjustment.

Patient preparation

In general, ahead of a cellular therapy session, the patient's inflammatory status, nutritional status, and absence of active infections are evaluated. Some protocols require adjustments to medication or specific habits; the medical team defines those based on the individual case.

Preparation is not a formality: it directly affects how the tissue responds to the intervention.

The application session

In general, a cellular therapy session takes place under direct medical supervision. The route of administration varies according to the objective: it may be systemic or local, depending on the tissue being targeted. The duration of the session depends on the protocol and the patient's response.

If symptoms such as difficulty breathing, chest pain, sudden neurological changes, or new visual symptoms appear during or after a session, that requires emergency attention immediately, not a message to the clinic.

Follow-up

Follow-up is part of the protocol, not an optional addition. Biomarkers, symptoms, function, and objective response to the intervention are reviewed. That follow-up continues when the patient returns to their place of residence: medical supervision does not end with the last session.

flowchart TD
    A["Initial assessment: in person or remote"] --> B["Individual protocol definition"]
    B --> C["Patient preparation"]
    C --> D["Application session under medical supervision"]
    D --> E["Follow-up with biomarkers"]
    E --> F{"Was the objective reached?"}
    F -->|"Yes"| G["Closure and remote follow-up"]
    F -->|"Adjustment needed"| B

What the evidence says and what remains under investigation

Speaking honestly about stem cell treatment means separating three categories: what is clinically accepted, what is under active study, and what lacks sufficient basis to be offered as a medical intervention.

What is accepted

Hematopoietic stem cell transplantation for certain diseases of the blood and immune system is an established procedure, with decades of regulated practice. Outside that scope, some uses in degenerative joint diseases are supported by controlled studies, though protocols are not universally standardized.

What remains under investigation

There are active lines of research in neurodegenerative diseases, autoimmune conditions, cardiac regeneration, and cellular longevity. The results are sufficient to justify further study; they are not sufficient to state that the treatment is effective in a general sense or for all people with those conditions. Candidacy is evaluated case by case.

What does not apply

No stem cell treatment independently resolves conditions such as active cancer, advanced Alzheimer's, or other serious systemic conditions. Any clinic that claims otherwise operates outside what the evidence allows us to say. That is not a legal disclaimer: it is a description of where the science currently stands.

Candidacy for a regenerative protocol is not decided by a diagnosis on paper. It is decided at the assessment, with the studies in hand and the objective clearly defined.

Stem cell treatment in Mexico: what to consider when choosing a clinic

Mexico has regulatory frameworks for cellular therapies, though their application varies across centers. When evaluating where to receive care, certain criteria matter more than location or the visual presentation of a website.

• Direct medical supervision during every session, not only at the assessment.
• A written protocol with objectives, number of sessions, biomarkers to be measured, and criteria for adjustment.
• An explicit distinction between what is accepted and what is under investigation for your specific condition.
• Genuine follow-up after the procedure, even when the patient returns to another city or country.
• Verifiable credentials for the team responsible for the intervention.

If you want to go deeper into how to evaluate a regenerative medicine center before making a decision, our article on how to evaluate a stem cell therapy clinic in Mexico develops those criteria in greater detail.

A plan delivered in writing is not a formality: it is the signal that the medical team understood your case before proposing a protocol.

Frequently asked questions about stem cell treatment

Frequently asked questions

Is stem cell treatment regulated in Mexico?

Yes. In Mexico, cellular therapies are regulated by health authorities. Application varies across centers, which is why it is important to verify that the medical team holds verifiable credentials and that the protocol is delivered in writing before the intervention begins.

Is every person a candidate for stem cell treatment?

No. Candidacy is determined at the clinical assessment, based on health history, laboratory results, and the objective of the intervention. Certain conditions contraindicate this type of therapy, and that can only be established case by case under medical supervision.

How many sessions does a stem cell treatment involve?

It depends on the individual protocol. There is no fixed number applicable to all cases. The number of sessions in the series is defined at the assessment, based on the condition, the clinical objective, and the patient's response throughout follow-up.

Does stem cell treatment resolve diseases?

Current medical practice does not allow us to state that stem cell treatment resolves diseases in a generalized way. There are accepted applications, others under active investigation, and areas where the evidence is not sufficient. Each indication is evaluated with clinical judgment, not general claims.

Can I receive follow-up if I return to my city after treatment?

Yes. Follow-up continues when the patient returns to their place of residence. Medical supervision does not end with the last session: it includes biomarker review and evaluation of the protocol's response over time.

For those researching these options in depth, Mayo Clinic and MedlinePlus are general patient reference resources, in English and Spanish respectively, where background information on regenerative medicine can be found.